ID: ALA1644702

Max Phase: Preclinical

Molecular Formula: C14H13N3O3S

Molecular Weight: 303.34

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  COc1ccc(OCc2nn3c(=O)cc(C)nc3s2)cc1

Standard InChI:  InChI=1S/C14H13N3O3S/c1-9-7-13(18)17-14(15-9)21-12(16-17)8-20-11-5-3-10(19-2)4-6-11/h3-7H,8H2,1-2H3

Standard InChI Key:  OOEDMOKWFYRVSN-UHFFFAOYSA-N

Associated Targets(non-human)

Xanthine dehydrogenase/oxidase 52 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Xanthine dehydrogenase 2296 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 303.34Molecular Weight (Monoisotopic): 303.0678AlogP: 2.05#Rotatable Bonds: 4
Polar Surface Area: 65.72Molecular Species: NEUTRALHBA: 7HBD: 0
#RO5 Violations: 0HBA (Lipinski): 6HBD (Lipinski): 0#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: CX LogP: 2.33CX LogD: 2.33
Aromatic Rings: 3Heavy Atoms: 21QED Weighted: 0.74Np Likeness Score: -1.94

References

1. Sathisha KR, Khanum SA, Chandra JN, Ayisha F, Balaji S, Marathe GK, Gopal S, Rangappa KS..  (2011)  Synthesis and xanthine oxidase inhibitory activity of 7-methyl-2-(phenoxymethyl)-5H-[1,3,4]thiadiazolo[3,2-a]pyrimidin-5-one derivatives.,  19  (1): [PMID:21163661] [10.1016/j.bmc.2010.11.034]

Source